catalent glp-1 x Novo: and Antitrust Concerns as Industry Reacts to the $16.5B Acquisition Losing weight Catalent CEO to remain in

Recognizing the demand for the diabetes drug Ozempic among individuals seeking off label weight loss benefits, Novo Nordisk introduced another variant of semaglutide called Wegovy

the American direct to consumer pharmaceutical company HIMs has done exactly that, responding to Ozempics supply shortage

Effect of encapsulation on the anti-inflammatory properties of superoxide dismutase after oral administration

& Kosower, N

They are synthetic versions of the naturally occurring GLP-1 hormone that plays a crucial role in regulating blood sugar levels by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying